journal article·2022-07Open access

Gold-seaurchin based immunomodulator enabling photothermal intervention and αCD16 transfection to boost NK cell adoptive immunotherapy

Xinyi Lin, Feida Li, Qing Gu, Xiaoyan Wang, Youshi Zheng, Jiong Li, Jianhua Guan, Cuiping Yao, Xiaolong Liu

Acta Biomaterialia· Volume 146

Abstract

Despite huge potentials of NK cells in adoptive cell therapy (ACT), formidable physical barriers of the tumor tissue and deficiency of recognizing signals on tumor cells severely prevent NK cell infiltrating, activating and killing performances. Herein, a nano-immunomodulator AuNSP@αCD16 (CD16 antibody encoding plasmid) is explored to remodel the tumor microenvironment (TME) for improving the antitumor effects of adoptive NK cells. The as-prepared AuNSP, with a seaurchin-like gold core and a cationic polymer shell, exhibited a high gene transfection efficiency and a stable NIR-II photothermal capacity. The AuNSP could trigger mild photothermal intervention to partly destroy tumors and collapse the dense physical barriers, making a permeable TME for NK cell infiltration. What's more, the AuNSP could achieve αCD16 gene transfection to modify tumor surface with CD16 antibody, marking a unique structure on tumor cells for NK cell recognition and then lead to strong NK cell activation by CD16-mediated antibody-dependent cellular cytotoxicity (ADCC). As expected, the designed AuNSP@αCD16 induced an immune-favorable TME for NK cell performing killing functions against solid tumors, increasing the release of cytolytic granules and proinflammatory cytokines, which ultimately achieved a robustly boosted NK cell-based immunotherapy. Hence, the AuNSP@αCD16-mediated TME reconstituting strategy provides a substantial perspective for NK-based ACT on solid tumors. STATEMENT OF SIGNIFICANCE: In adoptive cell therapy (ACT), natural killer (NK) cells exhibit greater off-the-shelf utility and improved safety comparing with T cells, but the efficacy of NK cell therapy is severely compromised by formidable physical barriers of the tumor tissue and deficiency of NK cell recognizing signals on tumor cells. Herein, a nano-immunomodulator AuNSP@αCD16, with the abilities of inducing mild photothermal intervention and modifying the tumor cell surface with αCD16, is explored to reconstruct an infiltration-favorable and activation-facilitating tumor microenvironment for NK cells to perform killing functions. Such a simple and safe strategy is believed as a very promising candidate for future NK-based ACT.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Soil erosion and sediment transport · Hydrology and Sediment Transport Processes · Hydrology and Watershed Management Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (78)

Show source-provided references
1. Chimeric antigen receptor therapy10.1056/NEJMra1706169 ↗
2. Engineering nano-therapeutics to boost adoptive cell therapy for cancer treatment10.1002/smtd.202001191 ↗
3. Machine learning-aided quantification of antibody-based cancer immunotherapy by natural killer cells in microfluidic droplets10.1039/D0LC00158A ↗
4. Enhanced intratumoural activity of CAR T cells engineered to produce immunomodulators under photothermal control10.1038/s41551-021-00781-2 ↗
5. CAR T Cells in Solid Tumors: blueprints for Building Effective Therapies10.3389/fimmu.2018.01740 ↗
6. Cancer immunoediting and resistance to T cell-based immunotherapy10.1038/s41571-018-0142-8 ↗
7. Equipping Natural Killer Cells with Specific Targeting and Checkpoint Blocking Aptamers for Enhanced Adoptive Immunotherapy in Solid Tumors10.1002/anie.202002145 ↗
8. Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive Immunotherapy10.1002/smll.201900903 ↗
9. Cancer immunotherapy based on natural killer cells: current progress and new opportunities10.3389/fimmu.2019.01205 ↗
10. Pharmacological targeting of natural killer cells for cancer immunotherapy10.1111/cas.14418 ↗
11. Exploiting NK cell surveillance pathways for cancer therapy10.3390/cancers11010055 ↗
12. NK cells: an attractive candidate for cancer therapy10.1002/jcp.28657 ↗
13. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy10.1016/j.canlet.2019.11.009 ↗
14. The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies10.1038/s41590-020-0728-z ↗
15. Targeting natural killer cells in cancer immunotherapy10.1038/ni.3518 ↗
16. NK cells for cancer immunotherapy10.1038/s41573-019-0052-1 ↗
17. In Vivo Tracking of Cell Viability for Adoptive Natural Killer Cell-Based Immunotherapy by Ratiometric NIR-II Fluorescence Imaging10.1002/anie.202106730 ↗
18. Redirecting natural killer cells to potentiate adoptive immunotherapy in solid tumors through stabilized Y-type bispecific aptamer10.1039/D1NR00836F ↗
19. Targeting natural killer cells in solid tumors10.1038/s41423-019-0224-2 ↗
20. Targeting NK-cell checkpoints for cancer immunotherapy10.1016/j.coi.2017.01.003 ↗
21. RBC Membrane Camouflaged Semiconducting Polymer Nanoparticles for Near-Infrared Photoacoustic Imaging and Photothermal Therapy10.1007/s40820-020-00429-x ↗
22. Donor-acceptor conjugated polymer-based nanoparticles for highly effective photoacoustic imaging and photothermal therapy in the NIR-II window10.1039/C9CC07821E ↗
23. Localized NIR-II photo-immunotherapy through the combination of photothermal ablation and in situ generated interleukin-12 cytokine for efficiently eliminating primary and abscopal tumors10.1039/D0NR06182D ↗
24. Artificial engineered natural killer cells combined with antiheat endurance as a powerful strategy for enhancing photothermal-immunotherapy efficiency of solid tumors
25. NIR-II Responsive Inorganic 2D Nanomaterials for Cancer Photothermal Therapy: recent Advances and Future Challenges10.1002/adfm.202101625 ↗
26. Organic Semiconducting Macromolecular Dyes for NIR-II Photoacoustic Imaging and Photothermal Therapy10.1002/adfm.202104650 ↗
27. Bioorthogonal-targeted 1064
28. Second near-infrared photothermal materials for combinational nanotheranostics10.1039/D0CS00664E ↗
29. Photoacoustic Imaging and Photothermal Therapy of Semiconducting Polymer Nanoparticles: signal Amplification and Second Near-Infrared Construction10.1002/smll.202004723 ↗
30. Second Near-Infrared Absorbing Agents for Photoacoustic Imaging and Photothermal Therapy10.1002/smtd.201900553 ↗
31. Self-assembled metallo-supramolecular nanoflowers for NIR/acidic-triggered multidrug release, long-term tumor retention and NIR-II fluorescence imaging-guided photo-chemotherapy10.1016/j.cej.2020.125882 ↗
32. Recent progress in the synergistic combination of nanoparticle-mediated hyperthermia and immunotherapy for treatment of cancer10.1002/adhm.202001415 ↗
33. Photothermal therapy promotes tumor infiltration and antitumor activity of CAR T Cells
34. Nanoengineered CAR-T biohybrids for solid tumor immunotherapy with microenvironment photothermal-remodeling strategy10.1002/smll.202007494 ↗
35. Remodeling of tumor microenvironment by tumor-targeting nanozymes enhances immune activation of CAR T cells for combination therapy
36. Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy10.1016/j.nantod.2020.101073 ↗
37. Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view10.7150/thno.56482 ↗
38. Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment10.7150/thno.40291 ↗
39. Thermoresponsive nanogel-encapsulated PEDOT and HSP70 inhibitor for improving the depth of the photothermal therapeutic effect10.1002/adfm.201600031 ↗
40. Human HSP70 promoter-based prussian blue nanotheranostics for thermo-controlled gene therapy and synergistic photothermal ablation10.1002/adfm.201802026 ↗
41. DNAzyme-adsorbed polydopamine@MnO2 core-shell nanocomposites for enhanced photothermal therapy via the self-activated suppression of heat shock protein 7010.1039/D0NR08845E ↗
42. Complementary autophagy inhibition and glucose metabolism with rattle-structured polydopamine@mesoporous silica nanoparticles for augmented low-temperature photothermal therapy and in vivo photoacoustic imaging10.7150/thno.44668 ↗
43. A remotely controlled NIR-II photothermal-sensitive transgene system for hepatocellular carcinoma synergistic therapy10.1039/D1TB00493J ↗
44. Stangl · Int. J. Cancer · 2018 · 142 · 191110.1002/ijc.31213 ↗
45. Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70/TLR2/NF-kB axis10.1080/2162402X.2017.1279372 ↗
46. Hollow mesoporous ruthenium nanoparticles conjugated bispecific antibody for targeted anti-colorectal cancer response of combination therapy10.1039/C9NR01904A ↗
47. Human natural killer cells for targeting delivery of gold nanostars and bimodal imaging directed photothermal/photodynamic therapy and immunotherapy10.20892/j.issn.2095-3941.2019.0112 ↗
48. Temperature-Feedback Nanoplatform for NIR-II Penta-Modal Imaging-Guided Synergistic Photothermal Therapy and CAR-NK Immunotherapy of Lung Cancer10.1002/smll.202101397 ↗
49. Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells10.1038/icb.2017.6 ↗
50. Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells10.3389/fimmu.2018.02873 ↗
51. Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers10.1158/1078-0432.CCR-20-0768 ↗
52. Incorporation of a Novel CD16-specific single-domain antibody into multispecific natural killer cell engagers with potent ADCC10.1021/acs.molpharmaceut.1c00208 ↗
53. Natural killer cells and current applications of chimeric antigen receptor-modified NK-92 cells in tumor immunotherapy10.3390/ijms20020317 ↗
54. Natural killer cells unleashed: checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy10.1016/j.smim.2017.07.011 ↗
55. CAR-NK cells: a promising cellular immunotherapy for cancer10.1016/j.ebiom.2020.102975 ↗
56. Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs10.3390/cancers13102500 ↗
57. Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells10.1007/s11523-015-0391-8 ↗
58. Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy10.1126/sciadv.aba8564 ↗
59. Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells10.3390/cancers13020312 ↗
60. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy10.1186/s12951-021-00952-y ↗
61. Emerging nanotechnological strategies to reshape tumor microenvironment for enhanced therapeutic outcomes of cancer immunotherapy10.1088/1748-605X/abe7b3 ↗
62. Versatile types of organic/inorganic nanohybrids: from strategic design to biomedical applications10.1021/acs.chemrev.8b00401 ↗
63. Improving cancer immunotherapy through nanotechnology10.1038/s41568-019-0186-9 ↗
64. Designing multi-branched gold nanoechinus for NIR light activated dual modal photodynamic and photothermal therapy in the second biological window10.1002/adma.201400703 ↗
65. Photoresponsive nanovehicle for two independent wavelength light-triggered sequential release of P-gp shRNA and doxorubicin to optimize and enhance synergistic therapy of multidrug-resistant Cancer10.1021/acsami.8b03823 ↗
66. Photo-responsive hollow silica nanoparticles for light-triggered genetic and photodynamic synergistic therapy10.1016/j.actbio.2018.07.007 ↗
67. Construction and humanization of a functional bispecific EGFR x CD16 diabody using a refolding system10.1111/j.1742-4658.2011.08417.x ↗
68. FRET Nanoflares for Intracellular mRNA Detection: avoiding False Positive Signals and Minimizing Effects of System Fluctuations10.1021/jacs.5b04007 ↗
69. A fluorescent turn on nanoprobe for simultaneous visualization of dual-targets involved in cell apoptosis and drug screening in living cells10.1039/C7NR03564K ↗
70. A facile strategy to functionalize gold nanorods with polycation brushes for biomedical applications10.1016/j.actbio.2014.05.002 ↗
71. The role of tannic acid and sodium citrate in the synthesis of silver nanoparticles10.1007/s11051-017-3973-9 ↗
72. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery10.2147/IJN.S128270 ↗
73. Bovine serum albumin stabilized iron oxide and gold bimetallic heterodimers: synthesis, characterization and Stereological study10.1002/aoc.5155 ↗
74. A novel and high performance enzyme-less sensing layer for electrochemical detection of methyl parathion based on BSA templated Au–Ag bimetallic nanoclusters10.1039/C8NJ00425K ↗
75. Redox-cleavable star cationic PDMAEMA by arm-first approach of ATRP as a nonviral vector for gene delivery10.1016/j.biomaterials.2009.09.055 ↗
76. Theranostic nanoparticles with disease-specific administration strategies10.1016/j.nantod.2021.101335 ↗
77. Advances in engineering local drug delivery systems for cancer immunotherapy10.1002/wnan.1632 ↗
78. Intratumoral injection of low-energy photon-emitting gold nanoparticles: a microdosimetric Monte Carlo-based model10.1021/acsnano.7b08242 ↗